Data / Form D filings / NUVO RESEARCH INC
NUVO RESEARCH INC: Form D filing
NUVO RESEARCH INC, a pharmaceuticals company in Mississauga, Ontario, Canada, filed a Form D with the SEC in 2011. The latest, on May 27, 2011, reports an offering of no set size with nothing sold yet to 44 investors.
Find out what NUVO RESEARCH INC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 7560 AIRPORT ROAD, UNIT 10, Mississauga, Ontario, Canada, L4T 4
- Phone
- (443) 213-0506
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Ontario, Canada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506
- SEC identifier (CIK)
- 1371679
The full lists. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Form D filings: 44,302 rows, $523.02, or the new rows each week for $92.05 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 27, 2011 | New notice | Indefinite | $0 | Indefinite | 44 | May 12, 2011 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Anthony E. Dobranowski | Director | |
| Theodore E. Stanley | Director | |
| Katina K. Loucaides | Executive Officer | |
| James L. Moulds | Executive Officer | |
| John C. London | Executive Officer, Director | |
| Stephen L. Lemieux | Executive Officer | |
| David A. Copeland | Director | |
| Klaus E. von Lindeiner | Director | |
| Daniel N. Chicoine | Executive Officer, Director | |
| Jacques E. Messier | Director | |
| Bradley S. Galer | Executive Officer | |
| Henrich R.K. Guntermann | Executive Officer, Director |
Every Form D from the week of May 23, 2011 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what NUVO RESEARCH INC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.